X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with AJANTA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs AJANTA PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES AJANTA PHARMA JUBILANT LIFE SCIENCES/
AJANTA PHARMA
 
P/E (TTM) x 26.3 24.9 105.6% View Chart
P/BV x 5.4 10.3 52.6% View Chart
Dividend Yield % 0.3 0.6 57.7%  

Financials

 JUBILANT LIFE SCIENCES   AJANTA PHARMA
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
AJANTA PHARMA
Mar-16
JUBILANT LIFE SCIENCES/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs1871,720 10.9%   
Low Rs651,103 5.9%   
Sales per share (Unadj.) Rs364.3194.6 187.2%  
Earnings per share (Unadj.) Rs6.845.2 15.1%  
Cash flow per share (Unadj.) Rs24.550.3 48.7%  
Dividends per share (Unadj.) Rs3.008.00 37.5%  
Dividend yield (eoy) %2.40.6 420.3%  
Book value per share (Unadj.) Rs164.9132.0 124.9%  
Shares outstanding (eoy) m159.2888.77 179.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.37.3 4.8%   
Avg P/E ratio x18.431.2 58.9%  
P/CF ratio (eoy) x5.128.1 18.3%  
Price / Book Value ratio x0.810.7 7.1%  
Dividend payout %43.817.7 247.7%   
Avg Mkt Cap Rs m20,061125,299 16.0%   
No. of employees `0006.2NA-   
Total wages/salary Rs m11,0522,570 430.0%   
Avg. sales/employee Rs Th9,383.0NM-  
Avg. wages/employee Rs Th1,786.9NM-  
Avg. net profit/employee Rs Th176.3NM-  
INCOME DATA
Net Sales Rs m58,03417,275 335.9%  
Other income Rs m191166 114.6%   
Total revenues Rs m58,22417,442 333.8%   
Gross profit Rs m5,7865,807 99.6%  
Depreciation Rs m2,812451 624.0%   
Interest Rs m3,23749 6,620.0%   
Profit before tax Rs m-725,474 -1.3%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,1450-   
Tax Rs m6961,460 47.7%   
Profit after tax Rs m1,0904,014 27.2%  
Gross profit margin %10.033.6 29.7%  
Effective tax rate %-965.926.7 -3,621.6%   
Net profit margin %1.923.2 8.1%  
BALANCE SHEET DATA
Current assets Rs m29,2807,639 383.3%   
Current liabilities Rs m38,9122,715 1,433.4%   
Net working cap to sales %-16.628.5 -58.2%  
Current ratio x0.82.8 26.7%  
Inventory Days Days8443 195.2%  
Debtors Days Days5179 64.4%  
Net fixed assets Rs m55,7126,914 805.8%   
Share capital Rs m155177 87.3%   
"Free" reserves Rs m20,96811,442 183.3%   
Net worth Rs m26,26511,721 224.1%   
Long term debt Rs m17,169149 11,545.9%   
Total assets Rs m88,60614,814 598.1%  
Interest coverage x1.0112.9 0.9%   
Debt to equity ratio x0.70 5,152.3%  
Sales to assets ratio x0.71.2 56.2%   
Return on assets %4.927.4 17.8%  
Return on equity %4.234.2 12.1%  
Return on capital %11.646.5 24.9%  
Exports to sales %37.855.1 68.5%   
Imports to sales %16.56.0 274.5%   
Exports (fob) Rs m21,9339,527 230.2%   
Imports (cif) Rs m9,5671,038 922.1%   
Fx inflow Rs m22,00410,422 211.1%   
Fx outflow Rs m11,7491,678 700.1%   
Net fx Rs m10,2558,744 117.3%   
CASH FLOW
From Operations Rs m8,0263,264 245.9%  
From Investments Rs m-1,744-2,093 83.3%  
From Financial Activity Rs m-4,447-1,186 375.1%  
Net Cashflow Rs m1,834-15 -12,394.9%  

Share Holding

Indian Promoters % 45.6 73.8 61.8%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 1.6 561.3%  
FIIs % 21.2 7.6 278.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 17.0 124.1%  
Shareholders   23,815 20,968 113.6%  
Pledged promoter(s) holding % 15.9 4.4 361.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   BIOCON LTD  WOCKHARDT LTD.  VENUS REMEDIES  PLETHICO PHARMA  GLENMARK PHARMA  

Compare JUBILANT LIFE SCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Chart Modest Gains(RoundUp)

Global financial markets ended the holiday shortened week with modest gains. The rally put behind days of decline as concerns regarding swift interest rates hikes were put to ease.

Related Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Feb 23, 2018 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 8-QTR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS